Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02878928 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety
A NA study of Depression and Anxiety, sponsored by AltheaDx.
- Completed
- Registry status
- NA
- Development phase
- 579
- Enrollment target
- 17
- Study locations
NCT02878928 is a NA study of Depression and Anxiety that has completed, run by AltheaDx. The registered enrollment target is 579 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (26% lower). The trial reports 17 study locations across 10 states.
The verdict
NCT02878928, a NA study of Depression and Anxiety, has completed, sponsored by AltheaDx.
- COMPLETED
- Registry status
- NA
- Development phase
- 579 participants
- Enrollment target
- 17
- Study locations
Study Summary
A prospective, multi-center, randomized, subject and outcome evaluator blind , parallel-group study evaluating the effect of pharmacogenetic-guided versus standard of care treatment for subjects diagnosed with depression and/or anxiety disorders.
Conditions Studied
Interventions
- GENETIC IDgenetix Neuropsychiatric Test Panel
Study Locations (17)
California
- Adnab Research - Rolling Hills
- Artemis Clinical Research - San Diego
- Adnab Research - Torrance
- Collaborative Neuroscience Network - Torrance
Florida
- Innovative Clinical Research - Lauderhill
- Innova Clinical Trials - Miami
- APG Research - Orlando
Georgia
- iResearch Atlanta - Decatur
- Meridian Clinical Research - Savannah
New York
- United Medical Associates - Binghamton
- Richmond Behavioral Associates - Staten Island
Louisiana
- Medpharmics - Metairie
Nebraska
- Meridian Clinical Research - Norfolk
North Carolina
- Carolina Partners in Mental HealthCare - Raleigh
Pennsylvania
- Detweiler Family Medicine - Lansdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 579 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02878928
The ClinicalTrials.gov registry entry for NCT02878928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 579 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (26% lower). The listed sponsor is AltheaDx, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IDgenetix Neuropsychiatric Test Panel is the first listed.
NCT02878928 reports 17 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02878928 about?
NCT02878928 is a clinical study titled "Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety". A prospective, multi-center, randomized, subject and outcome evaluator blind , parallel-group study evaluating the effect of pharmacogenetic-guided versus standard of care treatment for subjects diagnosed with depression and/or anxiety disorders.
What is the current status of trial NCT02878928?
This trial is currently completed. It is a NA study. The enrollment target is 579 participants. The study started on 2016-05. Estimated completion is 2016-12.
What conditions does trial NCT02878928 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT02878928?
The interventions under investigation include: IDgenetix Neuropsychiatric Test Panel (GENETIC).
Who is sponsoring clinical trial NCT02878928?
This trial is sponsored by AltheaDx, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02878928 being conducted?
This trial has 17 study locations across California, Florida, Georgia, Louisiana, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.